[Therapeutic strategies in the treatment of breast cancer (author's transl)]. 1981

H Huber, and C Gattringer, and K Grünewald, and R Margreiter, and G Mikuz, and H Frommhold, and H J Senn, and H Braunsteiner

Breast cancer is the most common cause of cancer death in women. The probability of being cured of this disease is below 50%. However, for certain stages of disease prognosis can be improved by the application of modern therapeutic strategies. The present paper deals firstly with the relationship between prognosis, staging, and tumour cell characteristics (receptor status and cell kinetic findings). Thereafter, selection and efficacy of cytotoxic chemotherapy and endocrine treatment is discussed and related to the prognostic different entities. The current therapeutic regimen of our group is outlined.

UI MeSH Term Description Entries
D008207 Lymphatic Metastasis Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system. Lymph Node Metastasis,Lymph Node Metastases,Lymphatic Metastases,Metastasis, Lymph Node
D008408 Mastectomy Surgical procedure to remove one or both breasts. Mammectomy,Mammectomies,Mastectomies
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D011960 Receptors, Estrogen Cytoplasmic proteins that bind estrogens and migrate to the nucleus where they regulate DNA transcription. Evaluation of the state of estrogen receptors in breast cancer patients has become clinically important. Estrogen Receptor,Estrogen Receptors,Estrogen Nuclear Receptor,Estrogen Receptor Type I,Estrogen Receptor Type II,Estrogen Receptors Type I,Estrogen Receptors Type II,Receptor, Estrogen Nuclear,Receptors, Estrogen, Type I,Receptors, Estrogen, Type II,Nuclear Receptor, Estrogen,Receptor, Estrogen
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D004967 Estrogens Compounds that interact with ESTROGEN RECEPTORS in target tissues to bring about the effects similar to those of ESTRADIOL. Estrogens stimulate the female reproductive organs, and the development of secondary female SEX CHARACTERISTICS. Estrogenic chemicals include natural, synthetic, steroidal, or non-steroidal compounds. Estrogen,Estrogen Effect,Estrogen Effects,Estrogen Receptor Agonists,Estrogenic Agents,Estrogenic Compounds,Estrogenic Effect,Estrogenic Effects,Agents, Estrogenic,Agonists, Estrogen Receptor,Compounds, Estrogenic,Effects, Estrogen,Effects, Estrogenic,Receptor Agonists, Estrogen
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

H Huber, and C Gattringer, and K Grünewald, and R Margreiter, and G Mikuz, and H Frommhold, and H J Senn, and H Braunsteiner
January 1974, Langenbecks Archiv fur Chirurgie,
H Huber, and C Gattringer, and K Grünewald, and R Margreiter, and G Mikuz, and H Frommhold, and H J Senn, and H Braunsteiner
May 1977, MMW, Munchener medizinische Wochenschrift,
H Huber, and C Gattringer, and K Grünewald, and R Margreiter, and G Mikuz, and H Frommhold, and H J Senn, and H Braunsteiner
June 1975, Geburtshilfe und Frauenheilkunde,
H Huber, and C Gattringer, and K Grünewald, and R Margreiter, and G Mikuz, and H Frommhold, and H J Senn, and H Braunsteiner
January 1979, Journal belge de radiologie,
H Huber, and C Gattringer, and K Grünewald, and R Margreiter, and G Mikuz, and H Frommhold, and H J Senn, and H Braunsteiner
January 1979, Zentralblatt fur Chirurgie,
H Huber, and C Gattringer, and K Grünewald, and R Margreiter, and G Mikuz, and H Frommhold, and H J Senn, and H Braunsteiner
January 1974, Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis,
H Huber, and C Gattringer, and K Grünewald, and R Margreiter, and G Mikuz, and H Frommhold, and H J Senn, and H Braunsteiner
December 1976, Therapeutische Umschau. Revue therapeutique,
H Huber, and C Gattringer, and K Grünewald, and R Margreiter, and G Mikuz, and H Frommhold, and H J Senn, and H Braunsteiner
January 1975, Radiologia clinica,
H Huber, and C Gattringer, and K Grünewald, and R Margreiter, and G Mikuz, and H Frommhold, and H J Senn, and H Braunsteiner
March 1977, Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis,
H Huber, and C Gattringer, and K Grünewald, and R Margreiter, and G Mikuz, and H Frommhold, and H J Senn, and H Braunsteiner
April 1982, Wiener klinische Wochenschrift,
Copied contents to your clipboard!